Sign In  |  Register  |  About Walnut Creek Guide  |  Contact Us

Walnut Creek, CA
September 01, 2020 1:43pm
7-Day Forecast | Traffic

  • Search Hotels in Walnut Creek Guide

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Humana (NY: HUM )

247.10 +11.32 (+4.80%)
Official Closing Price Updated: 7:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Humana

< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
37 38 Next >
Humana to Offload Substantial Stake In Kindred At Home Hospice & Personal Care Divisions
Humana Inc (NYSE: HUM) has agreed to divest a majority interest in the Hospice and Personal Care divisions of Humana's Kindred at Home (KAH Hospice) subsidiary... 
Via Benzinga
Humana Announces Agreement to Divest Majority Interest in Kindred at Home Hospice and Personal Care Divisions to Clayton, Dubilier & Rice
From Humana Inc.
Via Business Wire
Humana Board Declares Payment of Quarterly Dividend to Stockholders
From Humana Inc.
Via Business Wire
If You Invested $100 In Humana 10 Years Ago, Here's How Much You Would Have Today
Humana (NYSE:HUM) has outperformed the market over the past 10 years by 5.55% on an annualized basis producing an average annual return of 18.03%. Currently, Humana has a market capitalization of... 
Via Benzinga
Looking Into Humana Inc's Recent Short Interest
Humana Inc's (NYSE:HUM) short percent of float has fallen 16.42% since its last report. The company recently reported that it has 1.44 million shares sold short, which is 1.12% of... 
Via Benzinga
Humana’s Impact Report Focuses on Building Trust and Transparency in Journey to Health Equity
From Humana Inc.
Via Business Wire
Relationships
The past six months have not been kind to the stock market and this can be seen from a variety of angles. 
Via Talk Markets
UBS Upgrades Rating to Buy for Humana, Raises Price Target To $520
UBS upgraded its rating of Humana (NYSE:HUM) to Buy with a price target of $520.00, changing its price target from $486.00 to $520.00. Shares of Humana are trading up 2.2% over the last 24 hours, at... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2022
Upgrades 
Via Benzinga
What Centene’s Next Era in Managed Care Looks Like
New Centene CEO Sarah London faces pressure from activists to increase profits, and from government to deliver more care. 
Via InvestorPlace
Humana Expands National Commitment to Affordable Housing With Additional $25 Million Investment
From Humana Inc.
Via Business Wire
Humana Throws the First Pitch Event to Connect Minority-Owned Businesses to Top Humana Suppliers
From Humana Inc.
Via Business Wire
This Favorable Sign Appears On Humana's Chart
If history is any guide, there may be good fortune ahead for shares of Humana (NYSE:HUM). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock. 
Via Benzinga
Biden To Propose Change To Obamacare To Extend Subsidies For Families: WSJ
Via Benzinga
Here's How Much You Would Have Made Owning Humana Stock In The Last 5 Years
Humana (NYSE:HUM) has outperformed the market over the past 5 years by 1.74% on an annualized basis producing an average annual return of 15.84%. Currently, Humana has a market capitalization of $55.72... 
Via Benzinga
Tri-County Health and Wellness Center Offers Quality Primary Care Services
Via Get News
House Passes Bill To Cap Out-of-Pocket Insulin Costs To No More Than $35/Month
The House of Representatives voted to approve legislation that would limit cost-sharing for insulin under private health insurance and Medicare.  
Via Benzinga
Humana Foundation $5.5 Million Investment Sustains Health Equity Momentum in Targeted Communities
From Humana Inc.
Via Business Wire
Humana Inc. to Release First Quarter 2022 Results on April 27, 2022
From Humana Inc.
Via Business Wire
Looking Into Humana Inc's Recent Short Interest
Humana Inc's (NYSE:HUM) short percent of float has fallen 15.72% since its last report. The company recently reported that it has 1.69 million shares sold short, which is 1.34% of... 
Via Benzinga
AM Best Assigns Issue Credit Rating to Humana Inc.’s Senior Unsecured Notes
From AM Best
Via Business Wire
Humana Completes Aggregate $750 Million Debt Offering
From Humana Inc.
Via Business Wire
Humana Prices $750 Million Debt Offering
From Humana Inc.
Via Business Wire
If You Invested $100 In This Stock 10 Years Ago, Here's How Much You Would Have Today
Humana (NYSE:HUM) has outperformed the market over the past 10 years by 5.66% on an annualized basis. Buying $100 In HUM: 10 years ago, an investor could have purchased 1.17... 
Via Benzinga
Sell Clover Health Stock in the Wake of Its Rally
CLOV stock recently enjoyed a considerable relief rally. However, its fundamentals remain as poor as ever and its gains will be fleeting. 
Via InvestorPlace
Clover Health: Praying to the Great Google
Although CLOV stock is down, it still has institutional support. Its leaders have past ties to Google and a deal could help both companies. 
Via InvestorPlace
Humana Announces Board of Directors Refreshment Plan
From Humana Inc.
Via Business Wire
Humana Board Declares Payment of Quarterly Dividend to Stockholders
From Humana Inc.
Via Business Wire
Humana, the Humana Foundation and UofL Announce up to $25 Million Investment in Health Equity Innovation Hub
From Humana Inc.
Via Business Wire
Humana Selected by Louisiana Health Department to Serve Medicaid Beneficiaries
From Humana Inc.
Via Business Wire
< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
37 38 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 WalnutCreekGuide.com & California Media Partners, LLC. All rights reserved.